| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.0085 | 0.9 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.0085 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0022 | 1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.21 | 7e-11 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.2 | 3e-10 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | 0.24 | 4e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.17 | 4e-09 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-08 |
| mRNA | chlorambucil | CTRPv2 | pan-cancer | AAC | 0.18 | 4e-08 |